查看購物車
  • Simplified Chinese
  • English
封面
市場調查報告書
商品編碼
1701969

女性健康診斷市場報告（按類型、應用、最終用戶和地區）2025 年至 2033 年

Women's Health Diagnostics Market Report by Type, Application, End User, and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 146 Pages | 商品交期: 2-3個工作天內

價格

2024年全球女性健康診斷市場規模達311億美元。展望未來， IMARC Group預計到2033年市場規模將達到542億美元，2025-2033年期間的成長率（CAGR）為6.4%。市場受到以下因素的推動：被診斷患有慢性病和生活方式相關疾病的人數不斷增加，診斷服務技術的重大發展，政府和公共組織透過眾多活動和舉措提高對女性健康的認知，即時診斷的接受率不斷提高，以及遠距醫療和遠距診斷行業的快速成長。

女性健康診斷有助於診斷女性患者的各種生物和社會心理狀況。它們協助解決性和陰道問題以及懷孕併發症，並控制骨質疏鬆症、更年期以及乳癌和子宮頸癌等某些惡性疾病。他們依靠一系列先進的實驗室測試、工具和程序，包括活體組織切片、超音波、化療和磁振造影 (MRI)。目前，多家醫療診斷中心正在提供廣泛的實驗室檢測解決方案，以加強對影響女性的罕見疾病和病症的診斷和管理。

女性健康診斷市場趨勢：

影響女性整體健康的健康問題日益普遍，這是對市場產生正面影響的主要因素之一。此外，人們的健康意識不斷增強，以及對早期診斷益處的認知不斷提高，正在催化全球對即時診斷 (POC) 女性健康診斷的需求。除此之外，由於生活壓力大以及酒精和藥物消費量增加導致不孕不育率上升，推動了女性對健康診斷的需求，以解決妊娠併發症並確保更健康的生活。此外，由於更年期會增加某些疾病的風險，包括心血管疾病和尿失禁，50 歲以上女性人口的顯著增加促進了市場的成長。除此之外，一些研究得出結論，女性在荷爾蒙變化期間更容易患上精神疾病，如憂鬱和焦慮。這項措施與許多國家的衛生機構為改善女性心理健康所採取的多項措施相結合，推動了全球市場的成長。

本報告回答的關鍵問題

  • 2024 年全球女性健康診斷市場規模？ 2025 年至 2033 年期間全球女性健康診斷市場的預期成長率為何？
  • 推動全球女性健康診斷市場發展的關鍵因素有哪些？
  • COVID-19 對全球女性健康診斷市場有何影響？
  • 全球女性健康診斷市場依類型分為哪些類型？
  • 根據應用，全球女性健康診斷市場是如何分佈的？
  • 根據最終用戶，全球女性健康診斷市場的分佈如何？
  • 全球女性健康診斷市場的主要區域有哪些？
  • 全球女性健康診斷市場的主要參與者/公司有哪些？

目錄

第1章：前言

第2章：範圍與方法

  • 研究目標
  • 利害關係人
  • 資料來源
    • 主要來源
    • 次要來源
  • 市場評估
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章：執行摘要

第4章：簡介

  • 概述
  • 主要行業趨勢

第5章：全球女性健康診斷市場

  • 市場概覽
  • 市場表現
  • COVID-19的影響
  • 市場預測

第6章：市場細分：依類型

  • 診斷設備
    • 關鍵部分
      • 切片裝置
      • 影像和監控設備
      • 配件和耗材
  • 診斷測試
    • 關鍵部分
      • 乳癌檢測
      • 子宮頸抹片檢查和HPV檢測
      • 懷孕測試和排卵測試
      • 其他

第7章：市場區隔：依應用

  • 乳癌
  • 傳染病檢測
  • 骨質疏鬆症檢測
  • 妊娠和生育能力測試
  • 性傳染病檢測
  • 其他

第8章：市場區隔：按最終用戶

  • 醫院和診斷中心
  • 居家護理

第9章：市場細分：依地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 市場區隔：依國家

第10章：SWOT分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 11 章：價值鏈分析

第 12 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第13章：價格分析

第 14 章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Abbott Laboratories
    • Becton Dickinson and Company
    • bioMerieux SA
    • Cardinal Health Inc.
    • Cook Group Incorporated
    • F. Hoffmann-La Roche AG
    • General Electric Company
    • Hologic Inc.
    • Koninklijke Philips NV
    • Perkinelmer Inc.
    • Quest Diagnostics Inc.
    • Siemens AG
    • Thermo Fisher Scientific Inc.
Product Code: SR112025A4956

The global women's health diagnostics market size reached USD 31.1 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 54.2 Billion by 2033, exhibiting a growth rate (CAGR) of 6.4% during 2025-2033. The market is propelled by the rising number of individuals diagnosed with chronic and lifestyle-related diseases, significant technological developments in diagnostic services, increasing awareness about women's health through numerous campaigns and initiatives by the governments and public organizations, increasing acceptance rate of point-of-care diagnostics, and rapid growth in telemedicine and remote diagnostics industry.

Women's health diagnostics help diagnose various biological and psychosocial conditions of female patients. They assist in addressing sexual and vaginal issues and pregnancy complications and managing threatening diseases, such as osteoporosis, menopause, and certain cancers like breast and cervical. They rely on a series of advanced laboratory tests, tools, and procedures, which include biopsy, ultrasound, chemotherapy, and magnetic resonance imaging (MRI). Several healthcare diagnostics centers are currently offering an expansive range of laboratory testing solutions to enhance the diagnosis and management of rare diseases and conditions that affect women.

Women's Health Diagnostics Market Trends:

The rising prevalence of health issues that impact the overall well-being of women represents one of the major factors influencing the market positively. Moreover, the growing health consciousness, along with the increasing awareness about the benefits of early diagnosis, is catalyzing the demand for point-of-care (POC) women's health diagnostics across the globe. Apart from this, the rising rate of infertility on account of stressful lifestyles and the growing consumption of alcohol and drugs is driving the need for women's health diagnostics to address pregnancy complications and ensure a healthier life. Furthermore, as menopause can increase the risk of developing certain medical conditions, including cardiovascular diseases and urinary incontinence, a significant rise in the female population which is over 50 years is contributing to the market growth. Besides this, several research studies have concluded that women are more likely to experience psychiatric disorders, such as depression and anxiety, during hormonal changes. This, in confluence with several initiatives undertaken by health agencies of numerous countries to improve mental health of women, is propelling the market growth across the globe.

Key Market Segmentation:

Breakup by Type:

  • Diagnostic Devices
  • Biopsy Device
  • Imaging and Monitoring Devices
  • Accessories and Consumables
  • Diagnostic Tests
  • Breast Cancer Testing
  • PAP Smear and HPV Test
  • Pregnancy Testing and Ovulation Testing
  • Others

Breakup by Application:

  • Breast Cancer
  • Infectious Disease Testing
  • Osteoporosis Testing
  • Pregnancy and Fertility Testing
  • Sexually Transmitted Disease Testing
  • Others

Breakup by End User:

  • Hospital and Diagnostics Centers
  • Home Care

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Becton Dickinson and Company, bioMerieux SA, Cardinal Health Inc., Cook Group Incorporated, F. Hoffmann-La Roche AG, General Electric Company, Hologic Inc., Koninklijke Philips N.V., Perkinelmer Inc., Quest Diagnostics Inc., Siemens AG and Thermo Fisher Scientific Inc.

Key Questions Answered in This Report

  • 1.What was the size of the global women's health diagnostics market in 2024?
  • 2.What is the expected growth rate of the global women's health diagnostics market during 2025-2033?
  • 3.What are the key factors driving the global women's health diagnostics market?
  • 4.What has been the impact of COVID-19 on the global women's health diagnostics market?
  • 5.What is the breakup of the global women's health diagnostics market based on the type?
  • 6.What is the breakup of the global women's health diagnostics market based on the application?
  • 7.What is the breakup of the global women's health diagnostics market based on the end user?
  • 8.What are the key regions in the global women's health diagnostics market?
  • 9.Who are the key players/companies in the global women's health diagnostics market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Women's Health Diagnostics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Diagnostic Devices
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Biopsy Device
      • 6.1.2.2 Imaging and Monitoring Devices
      • 6.1.2.3 Accessories and Consumables
    • 6.1.3 Market Forecast
  • 6.2 Diagnostic Tests
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Breast Cancer Testing
      • 6.2.2.2 PAP Smear and HPV Test
      • 6.2.2.3 Pregnancy Testing and Ovulation Testing
      • 6.2.2.4 Others
    • 6.2.3 Market Forecast

7 Market Breakup by Application

  • 7.1 Breast Cancer
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Infectious Disease Testing
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Osteoporosis Testing
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Pregnancy and Fertility Testing
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Sexually Transmitted Disease Testing
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Others
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospital and Diagnostics Centers
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Home Care
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Abbott Laboratories
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Becton Dickinson and Company
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 bioMerieux SA
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Cardinal Health Inc.
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Cook Group Incorporated
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 F. Hoffmann-La Roche AG
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
    • 14.3.7 General Electric Company
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Hologic Inc.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Koninklijke Philips N.V.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Perkinelmer Inc.
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis
    • 14.3.11 Quest Diagnostics Inc.
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
      • 14.3.11.4 SWOT Analysis
    • 14.3.12 Siemens AG
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
      • 14.3.12.3 Financials
      • 14.3.12.4 SWOT Analysis
    • 14.3.13 Thermo Fisher Scientific Inc.
      • 14.3.13.1 Company Overview
      • 14.3.13.2 Product Portfolio
      • 14.3.13.3 Financials
      • 14.3.13.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Women's Health Diagnostics Market: Major Drivers and Challenges
  • Figure 2: Global: Women's Health Diagnostics Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Women's Health Diagnostics Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Women's Health Diagnostics Market: Breakup by Type (in %), 2024
  • Figure 5: Global: Women's Health Diagnostics Market: Breakup by Application (in %), 2024
  • Figure 6: Global: Women's Health Diagnostics Market: Breakup by End User (in %), 2024
  • Figure 7: Global: Women's Health Diagnostics Market: Breakup by Region (in %), 2024
  • Figure 8: Global: Women's Health Diagnostics (Diagnostic Devices) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 9: Global: Women's Health Diagnostics (Diagnostic Devices) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 10: Global: Women's Health Diagnostics (Diagnostic Tests) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Women's Health Diagnostics (Diagnostic Tests) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Women's Health Diagnostics (Breast Cancer) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Women's Health Diagnostics (Breast Cancer) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Women's Health Diagnostics (Infectious Disease Testing) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Women's Health Diagnostics (Infectious Disease Testing) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Women's Health Diagnostics (Osteoporosis Testing) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Women's Health Diagnostics (Osteoporosis Testing) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Women's Health Diagnostics (Pregnancy and Fertility Testing) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Women's Health Diagnostics (Pregnancy and Fertility Testing) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Women's Health Diagnostics (Sexually Transmitted Disease Testing) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Women's Health Diagnostics (Sexually Transmitted Disease Testing) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: Women's Health Diagnostics (Other Applications) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: Women's Health Diagnostics (Other Applications) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: Global: Women's Health Diagnostics (Hospital and Diagnostics Centers) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: Global: Women's Health Diagnostics (Hospital and Diagnostics Centers) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: Global: Women's Health Diagnostics (Home Care) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: Global: Women's Health Diagnostics (Home Care) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: North America: Women's Health Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: North America: Women's Health Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: United States: Women's Health Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: United States: Women's Health Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: Canada: Women's Health Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: Canada: Women's Health Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: Asia-Pacific: Women's Health Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: Asia-Pacific: Women's Health Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: China: Women's Health Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: China: Women's Health Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: Japan: Women's Health Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: Japan: Women's Health Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: India: Women's Health Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: India: Women's Health Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: South Korea: Women's Health Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: South Korea: Women's Health Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: Australia: Women's Health Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: Australia: Women's Health Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: Indonesia: Women's Health Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: Indonesia: Women's Health Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: Others: Women's Health Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: Others: Women's Health Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: Europe: Women's Health Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: Europe: Women's Health Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: Germany: Women's Health Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: Germany: Women's Health Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: France: Women's Health Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: France: Women's Health Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: United Kingdom: Women's Health Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: United Kingdom: Women's Health Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: Italy: Women's Health Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: Italy: Women's Health Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: Spain: Women's Health Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: Spain: Women's Health Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: Russia: Women's Health Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: Russia: Women's Health Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: Others: Women's Health Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: Others: Women's Health Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: Latin America: Women's Health Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: Latin America: Women's Health Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: Brazil: Women's Health Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: Brazil: Women's Health Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: Mexico: Women's Health Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 71: Mexico: Women's Health Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 72: Others: Women's Health Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 73: Others: Women's Health Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 74: Middle East and Africa: Women's Health Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 75: Middle East and Africa: Women's Health Diagnostics Market: Breakup by Country (in %), 2024
  • Figure 76: Middle East and Africa: Women's Health Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 77: Global: Women's Health Diagnostics Industry: SWOT Analysis
  • Figure 78: Global: Women's Health Diagnostics Industry: Value Chain Analysis
  • Figure 79: Global: Women's Health Diagnostics Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Women's Health Diagnostics Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Women's Health Diagnostics Market Forecast: Breakup by Type (in Million USD), 2025-2033
  • Table 3: Global: Women's Health Diagnostics Market Forecast: Breakup by Application (in Million USD), 2025-2033
  • Table 4: Global: Women's Health Diagnostics Market Forecast: Breakup by End User (in Million USD), 2025-2033
  • Table 5: Global: Women's Health Diagnostics Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 6: Global: Women's Health Diagnostics Market: Competitive Structure
  • Table 7: Global: Women's Health Diagnostics Market: Key Players